We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix,  Inc

Download Mobile App


ATTENTION: Due to the CORONAVIRUS EPIDEMIC, certain events are being rescheduled for a later date or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
06 May 2020 - 09 May 2020

Noninvasive Ventilators Improve COPD Outcomes

By HospiMedica International staff writers
Posted on 17 Feb 2020
Print article
Image: Home BiPAP devices improve respiratory care (Photo courtesy of Getty Images)
Image: Home BiPAP devices improve respiratory care (Photo courtesy of Getty Images)
Home bilevel positive airway pressure (BiPAP) is associated with lower risk of mortality, all-cause hospital admission, and intubation, according to a new study.

Researchers at the Mayo Clinic (Rochester, MN, USA) conducted a meta-analysis of randomized clinical trials (RCTs) and comparative observational studies that enrolled adults with chronic obstructive pulmonary disease (COPD) with hypercapnia who used home noninvasive positive pressure ventilation (NIPPV) devices for more than one month in order to evaluate associations between BiPAP and NIPPV devices and long-term outcomes. In all, 33 studies evaluating outcomes for 51,085 patients were included in the analysis.

The primary outcomes including mortality, all-cause hospital admissions, need for intubation, and quality of life. The results revealed that use of a noninvasive ventilator device (either BiPAP or NIPPV) was significantly associated with lower mortality (29.2%) compared to no device (22.3%). The use of a noninvasive ventilator device also led to fewer emergency department visits and hospitalizations, and lower rates of intubation if the patients were subsequently admitted to the hospital. The study was published on February 4, 2020, in JAMA.

“While there does seem to be some clear benefits to using devices such as BiPAP, we should be cautious as the studies included a lot of different types of patients with COPD. We still have a lot more to learn about which machine settings are best for different types of patients,” said lead author pulmonary and critical care physician Michael Wilson, MD. “In addition, although many studies in our review included quality of life measurements, we didn't see an improvement. While some studies showed better quality of life, other studies showed no difference.”

COPD is a debilitating lung disease that makes it difficult to breathe. Many of those who suffer from COPD also suffer from hypercapnia, the retention of carbon dioxide (CO2), a metabolism waste product normally expelled by the lungs during breathing. The combination of COPD and chronic hypercapnia may lead to acute respiratory failure and hospitalization. One of the recommended treatment options is NIPPV using a respiration machine with a mask that helps to improve breathing.

Related Links:
Mayo Clinic

Print article



view channel

Surgical Robots Market to Reach USD 13.1 Billion by 2027 Due to High Acceptance in Emerging Regions

The global surgical robots market is forecasted to reach USD 13.1 billion by 2027, driven mainly by low turn-around times and increased innovation in robotics over the coming years. Surgical robots are... Read more
Copyright © 2000-2020 Globetech Media. All rights reserved.